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The MRN complex is transcriptionally regulated by
MYCN during neural cell proliferation to control
replication stress
M Petroni1, F Sardina1, C Heil1, M Sahún-Roncero1, V Colicchia1, V Veschi1, S Albini2, D Fruci2, B Ricci1, A Soriani1, L Di Marcotullio1,
I Screpanti1, A Gulino1 and G Giannini*,3
The MRE11/RAD50/NBS1 (MRN) complex is a major sensor of DNA double strand breaks, whose role in controlling faithful DNA
replication and preventing replication stress is also emerging. Inactivation of the MRN complex invariably leads to developmental
and/or degenerative neuronal defects, the pathogenesis of which still remains poorly understood. In particular, NBS1 gene
mutations are associated with microcephaly and strongly impaired cerebellar development, both in humans and in the mouse
model. These phenotypes strikingly overlap those induced by inactivation of MYCN, an essential promoter of the expansion of
neuronal stem and progenitor cells, suggesting that MYCN and the MRN complex might be connected on a unique pathway
essential for the safe expansion of neuronal cells. Here, we show that MYCN transcriptionally controls the expression of each
component of the MRN complex. By genetic and pharmacological inhibition of the MRN complex in a MYCN overexpression model
and in the more physiological context of the Hedgehog-dependent expansion of primary cerebellar granule progenitor cells, we
also show that the MRN complex is required for MYCN-dependent proliferation. Indeed, its inhibition resulted in DNA damage,
activation of a DNA damage response, and cell death in a MYCN- and replication-dependent manner. Our data indicate the MRN
complex is essential to restrain MYCN-induced replication stress during neural cell proliferation and support the hypothesis that
replication-born DNA damage is responsible for the neuronal defects associated with MRN dysfunctions.
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The MRE11/RAD50/NBS1 (MRN) complex is a major sensor
of DNA double strand breaks (DSBs) that exerts essential
roles in DNA repair processes and in the DNA damage
response (DDR).1 Hypomorphic mutations of MRE11, NBS1
and RAD50 genes in humans are responsible for the Ataxia-
Telangiectasia like disorder (A-TLD), Nijmegen Breakage
Syndrome (NBS) and NBS like disorder (NBSLD),
respectively.1 These syndromes share common cellular
phenotypes related to their DNA repair defect (i.e., hypersen-
sitivity to DSB inducers, altered cell cycle checkpoints and
chromosomal instability), and may or may not include
combined immunodeficiency, germ cell defects and cancer
predisposition.2–4 Similar to other 'DDR-defective syndromes',
MRN genetic defects invariably result in neurological abnorm-
alities, such as progressive cerebellar ataxia in A-TLD
patients, and modest-to-severe microcephaly in NBS patients
and in the unique NBSLD case described so far.2–4 Of
relevance, craniofacial and digital abnormalities and gastro-
intestinal atresias are also sporadic features of NBS.2 The
essential role of the MRN complex in neural development has
been modeled in mice. Indeed, the conditional knockout of the
Nbs1 gene in the CNS leads to microcephaly, severe ataxia
and dramatically impaired cerebellar development, owing to a
proliferation arrest of granule cell progenitors (GCPs) and
apoptosis of postmitotic neurons.5 Nonetheless, themolecular
bases of the neurological phenotypes observed in the MRN-
defective syndromes are still poorly understood.
So far, very few papers have addressed how MRN complex
expression is controlled, most often reporting on its deregula-
tion in cancer cells. Indeed, MRE11 and RAD50 are repressed
by p63 and p73 in response to anticancer drugs,6 while
FOXM1 and c-myc stimulate and hypoxia represses NBS1
expression.7–9 MRN components are generally thought to be
constitutively expressed in mammalian tissues. However, it
has been noted that NBS1 expression levels are higher in
organs where DNA DSBs occur physiologically or at sites of
high proliferative activity,10 suggesting the MRN complex
might have an important role in cell proliferation. Intriguingly,
constitutive MRN knockout mice are unviable, indicating all
three components are involved in pathway/s whose integrity is
essential for mammalian development.1 All these observa-
tions fit with the emerging role of the MRN complex in
controlling faithful DNA replication by restarting stalled and
collapsed replication forks.11–16
Embryonic and postnatal cerebellar development and
GCPs expansion is largely dependent on the Hedgehog
(Hh) pathway and its downstream targetMycn.17 Together with
c-MYC and L-MYC, MYCN belongs to a family of transcription
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factors and key regulators of mammalian development.
Both c-Myc- and Mycn-deficient mice die at early embryonic
stages18 and show severe hypoplasia in several
organs including the nervous system.19–21 Their role in
directing neural stem and precursor cells fate, cycling and
metabolism is clearly established.22,23 Underlying its pivotal
role in CNS development and pre- and post-natal cerebellar
maturation, Mycn conditional KO in the nervous system
severely impairs brain development and results in
microcephaly with extreme cerebellar hypoplasia,24 all phe-
notypes shared with the CNS-restricted Nbs1 knockout.5
Intriguingly, MYCN haploinsufficiency, due to heterozygous
mutations or deletions, causes the Feingold syndrome, an
inherited human disease characterized by microcephaly,
digital anomalies, facial dysmorphisms, gastrointestinal atre-
sias and variable learning disabilities.25–27 Thus, MYCN and
NBS1 inactivation lead to overlapping phenotypes both in
mice and humans.
As many other proto-oncogenes, MYC overexpression
induces replication stress and aDDRbymultiplemechanisms,
which include direct binding on and boosting of DNA
replication factories.28–31 Interestingly, c-MYC promotes the
expression of DDRproteins such asCHK1 andWRNhelicase,
both of which are necessary for MYC-dependent cancer cell
proliferation/survival,32,33 indicating that restraining replication
stress is necessary and intrinsically promoted by MYC.
Whether MYC-dependent replication stress might occur in
more physiological conditions and independent of MYC
oncogenic activity, and how is this eventually controlled is
presently unknown.
The substantial overlap of the cerebellar phenotypes of
MYCN and NBS1 genetic defects in humans and mice
prompted us to explore the functional connections between
MYCN and the MRN complex in neural cells. We report here
that the MRN complex is induced by MYCN and is essential to
restrain MYCN-dependent replication stress during neural cell
proliferation.
Results
MYCN transcriptionally regulates MRN complex expres-
sion. Proliferating and retinoic acid (RA)-differentiated
human LAN-5 cells have been previously used as a
neuron-like model to assess the function of DNA repair
pathways.34 In these and similar settings, where MYCN
repression is required for cell growth inhibition and morpho-
logical differentiation induced by RA35,36 (Supplementary
Figure S1A), we reproducibly observed the downregulation
of MRE11 and NBS1 (Figure 1a), while a sharp RAD50
decrease occurred only in some models. Owing to the
coregulation of MYCN and MRN complex during RA-induced
differentiation of neuron-like cells, we used both overexpres-
sion and knockdown approaches to address whether
MYCN directly controls MRN complex expression. Transient
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Figure 1 The MRN complex is transcriptionally controlled by MYCN. (a) Western blot (WB) analysis of MYCN and MRN protein components in the LAN5 and SK-N-BE
neuron-like cell models. (b, c) Analysis of the expression of the indicated proteins (b) and transcripts (c) in the SHEP Tet 21/N inducible-MYCN overexpression model. Transcripts
expression were normalized on GAPDH levels and given as fold induction compared with MYCN uninduced controls. (d) Organization of the promoters of the MRE11, RAD50 and
NBS1 human genes. Typical E-Boxes (CACGTG) are present in the human MRE11, RAD50 and NBS1 promoters at the indicated positions. Black arrows indicate exons one and
two, and nucleotide positions are given from the first nucleotide of exon 1, for each gene. P1, P2 and P3 indicate GC-reach sequences of the NBS1 promoter. (e) PCR
amplification of immunoprecipitated chromatin prepared from MYCN induced or uninduced SHEP Tet 21/N (MYCN+/− ) cells. Chromatin was incubated with anti-IgG (IgG),
anti-acetyl histone 3 (acH3) or with anti-MYCN antibodies. Prothymosin alpha (Ptmα) and β-actin primers were used as positive and negative controls, respectively
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(in SK-N-SH) or inducible MYCN overexpression (in the
SHEP Tet21/N cell model, since now on MYCN+ and
MYCN− cells) clearly increased the expression of the three
components of the MRN complex at the protein and mRNA
levels (Figures 1b and c and Supplementary Figure S1B).
Conversely, MYCN knockdown caused MRN complex reduc-
tion in LAN-1 cells (Supplementary Figure S1C), suggesting
that MYCN might directly control MRE11, RAD50 and NBS1
transcription in neuron-like cells. Unique canonical CACGTG
MYC binding sequences (E-boxes) are located in the intron 1
of both MRE11 and NBS1 human genes, while two E-boxes
are present in human RAD50 gene (Figure 1d). A similar
organization also occurred in the homologous genes, in
mice (Supplementary Figure S2A). Importantly, MYCN bound
transcriptionally active H3-acetylated chromatin encompass-
ing the E-boxes in human MRE11 and NBS1 genes, in
addition to its known target pro-thymosin-α (Figure 1e). It also
bound RAD50 E-box2, but not RAD50 E-box1 and actin
promoter (Figure 1e). Moreover, in a luciferase reporter
assay, MYCN activated a NBS1 promoter fragment contain-
ing the wild-type intron-1 E-Box (Supplementary Figure S1D),
but not its mutant version, further supporting a direct
transcriptional regulation of the MRN complex.
The MRN complex is required for MYCN-dependent
proliferation. Subsequently, we addressed the role of the
MRN complex in MYCN-dependent proliferation in neuron-
like cultures. Partial NBS1 knockout with two different shRNAi
impaired cell proliferation selectively in MYCN+ cells
(Figures 2a and b, Supplementary Figure S3A). Moreover,
inhibition of the MRN complex activity with the recently
described MRE11 pharmacological inhibitor mirin37 impaired
Tet21/N cell proliferation, with a much stronger effect on
MYCN+ cells (Figure 2c). Interestingly, mirin caused no
significant death, but altered cell cycle profile and impaired
BrdU incorporation, in MYCN− cells (Figure 2d and
Supplementary Figures S3B and C), suggesting it might
impair cell proliferation by delaying cell cycle progression in
this setting. Notably, however, mirin did not impair BrdU
incorporation and mainly induced cell death in MYCN+ cells,
as indicated by death cell count and PARP1 cleavage
(Figure 2d), in addition to cell cycle modifications
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Figure 2 The MRN complex is required for MYCN-dependent proliferation in neuron-like cells. (a) WB analysis of the expression of the indicated proteins and (b) cells counts
performed in MYCN+/− cells in which NBS1 was downregulated by two different IPTG-inducible shRNAs (shNBS1-35 and sh-NBS-36). (c) Cell counts performed on the MYCN+/-
cells treated withmirin or vehicle (DMSO). (d) Cell death was monitored by trypan blue exclusion assay in MYCN+/− cells with or withoutmirin treatment and by detection of the
cleaved form of PARP1 via immunoblot (cPARP in the inset)
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(Supplementary Figures S3B and C). Therefore, MRN
complex function seems to be required for a safe progression
through the cell cycle in neuron-like cell models and to
prevent cell death in particular in a MYCN-dependent context.
The MRN complex controls MYCN-dependent replication
stress. MYC protein overexpression has been consistently
shown to cause DNA damage, DDR and genetic
instability.38–41 This seems to be largely, although not
exclusively, due to the induction of replication stress. Indeed,
it increases the density of early replicating origins and
triggers elevated replication fork stalling or collapse.30
Several transcription-dependent and -independent mechan-
isms have been shown to contribute to this end.28,29 We have
recently shown that MYCN expression in neuron-like models
also induce a time-dependent activation of ATM, H2AX and
p53S15 phosphorylation, possibly as consequence of a
replication stress-dependent DDR.42 Consistent with this
hypothesis, MYCN induced accumulation of RPA and CHK1
phosphorylation (Figure 3a), known reporters of the replica-
tion stress-dependent ATR activation, and was also asso-
ciated with slightly increased amounts of chromatin-bound
RPA (Figure 3b). In time, also ATM, H2AX and p53S15
phosphorylation increased in MYCN+ cells, consistent with
the previously reported activation of a DDR42 and with the
appearance of DNA damage (Figure 3c). Moreover, impairing
regeneration of nucleotide pools via hydroxyurea induced a
replication stress response (indicated by RPA and CHK1
phosphorylation) more promptly and more efficiently in
MYCN+ compared with MYCN− cells (Figure 3d), further
supporting the idea that MYCN increases replication stress in
neuron-like models.
Because the MRN complex is involved in restarting stalled
and collapsed replication forks,11,12 we tested whether it might
be required to protect cells from MYCN-dependent replication
stress and DNA damage. Indeed, MRN inhibition viamirinwas
clearly associated with increased signs of DDR (including
ATM, H2AX and p53S15 phosphorylation) even at time points
in which they are barely detectable in untreated MYCN+ cells
(Figure 4a). Consistently, mirin treatment caused the accu-
mulation of DNA DSB in MYCN+, but not in MYCN− cells
(Figure 4b). Supporting the occurrence of replication stress-
associated DNA lesions, mirin also caused accumulation of
multiple 53BP1 foci in a larger number of MYCN+ compared
with MYCN− cells (Figure 4c). Not unexpectedly, we failed to
detect phosphorylation of CHK1 upon mirin treatment
(Figure 4a and Supplementary Figure S3E), which is coherent
with the reported requirement of MRE11 exonuclease
function for RPA foci formation and ATR-CHK1 pathway
activation.13,43,44 Indeed,mirin also inhibited CHK1 phosphor-
ylation induced by hydroxyurea in MYCN+ cells
(Supplementary Figure S3D). Consistent with the absence
of activation of the ATR-CHK1-dependent checkpoint despite
replication stress, mirin did not lead to inhibition of DNA
synthesis in MYCN+ cells (Supplementary Figure S3B).
Overall, these data suggest that the MRN complex prevents
MYCN-dependent DNA damage by controlling MYCN-
dependent replication stress. To directly prove that induction
of DNA damage by mirin is related to replication stress, we
synchronized MYCN+ cells in the S phase of the cell cycle, by
thymidine block; upon release, we exposed the cells to mirin
either immediately (S-phase cells) or after 6 h, when most of
the cells were in the G2/M phase (Figures 4d and e). Exposure
of S-phase-enriched MYCN+ cells to mirin resulted in both
high levels of DNA DSBs and cell death, while this did not
occur if cells were treated in the G2/M phase (Figure 4f)
confirming that mirin-induced and MYCN-dependent DNA
damage and cell death require DNA replication.
The Mycn-MRN axis prevents the deleterious effects of
replication stress during Hh- and Mycn-dependent GCP
proliferation. In mice, an Hh-dependent proliferative expan-
sion of the external granule cell layer of the cerebellum
characterizes the first 5–10 days post partum, supported by
the expression of the Hh target Mycn.17 Shortly after, Hh
signal declines, external granule cell layer cells migrate
through the molecular and Purkinje layers towards the
internal granule cell layer, and their differentiation progres-
sively takes over, leading to completion of the cerebellar
development by the end of postnatal week 3. Accordingly,
Mycn expression declines and differentiation markers such
as Zic1 and Gabra6 rise up (Figures 5a and b). Concerning
the three partners of the MRN complex, their protein and
mRNA expression remains high during the Hh-driven external
granule cell layer expansion and progressively declines
during the differentiation phase, to reach very low levels by
post-natal day 21, when cerebellar maturation is complete
(Figures 5a and b). Isolated GCPs cultured in the absence of
Hh pathway stimulation spontaneously stop proliferation and
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Figure 3 MYCN induces replication stress. (a) WB analysis of the expression of
the indicated proteins and phosphoepitopes in MYCN+/− cells at various time points.
(b) WB analysis of RPA32 protein expression in total extracts and in the chromatin-
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and negative controls of chromatin fraction, respectively. The ponceau staining was
used as the loading control. (c) Neutral comet assay of MYCN+/− cells in basal
condition. (d) WB analysis of the expression of the indicated protein in MYCN+/−
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undergo differentiation. This is underlined by a sharp
decrease in Mycn expression and acquisition of morphologi-
cal features and markers of differentiation, such as β3-tubulin
expression (Figure 5c inset). Also, in isolated GCP primary
cultures, growth arrest and differentiation were accompanied
by a progressive decline in the MRN complex expression,
paralleled by a reduction in the expression of Mre11, Rad50
and Nbs1 transcripts (Figures 5c and d). In these settings, Hh
pathway activation via the Smoothened agonist (SAG)
induces the Gli1 transcription factor which stimulates cell
proliferation and prevents differentiation by transcriptionally
regulating the expression of a large number of targets,17
among which is Mycn (Figure 5e). Hh pathway activation also
increased Mre11 and Nbs1 expression and to a lesser extent
also Rad50 expression (Figures 5e and f). Importantly, Mycn
knockdown impaired SAG-dependent induction of the MRN
complex (Figure 5g), indicating that Mycn controls MRN
complex expression levels during Hh-dependent GCPs
proliferation.
Interestingly, MYCN expression obtained in MYCN+
neuron-like cells was not dramatically different from that
observed in freshly isolated GCPs (DIV0, Figure 6a), while
both of them were far above the levels obtained in cultured
SAG-treated GCPs (Figure 6a). Very importantly, mirin
induced cell death selectively in SAG-treated, but not in non-
proliferating, GCPs (Figure 6b), suggesting that MRN function
is indispensable even in the more physiological context of Hh-
induced and Mycn-dependent GCPs proliferation. Of rele-
vance, mirin treatment yielded accumulation of multiple
53BP1 foci and typical signs of DDR (including p53
accumulation and H2AX phosphorylation) in Hh-induced and
Mycn-dependent GCPs proliferation, but not in non-
proliferating GCPs (Figures 6c and d) supporting the
hypothesis that MRN complex induction by Mycn is
required to prevent the accumulation of DNA damage due to
Mycn-dependent replication stress during the physiological
expansion of the cerebellar external granule cell layer.
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Discussion
Prompted by the striking similarities in the CNS phenotypes
associated with MYCN and NBS1 genetic defects, we
investigated on the functional links between MYCN and the
MRN complex. The expression of the MRN components is
generally believed to be ubiquitous and largely constitutive.
However, here, we provide evidence that Mycn and the MRN
complex are coregulated during mouse cerebellar develop-
ment and in the Hh-dependent proliferation of primary
cerebellar GCPs. Moreover, MYCN transcriptionally controls
the MRN complex expression in human neuron-like models,
and its depletion impairs Hh-induced regulation of the MRN
complex in primary GCPs. Interestingly, MYCN coordinates
the expression of a complex pattern of S-phase promoting
factors, including MCM proteins and other ORC components,
cyclin/cdk complexes, their regulatory kinases and phospha-
tases (i.e., WEE1 and CDC25) and CDK inhibitors.45 In
addition, it also promotes the expression of DNA repair factors
involved in S-phase transition, including RAD51, CHK1 and
BLM.45–47 Therefore, our data on the MRN complex regulation
might be part of a much broader picture suggesting that a
main orchestrator of neural progenitor cell expansion, such as
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MYCN, may require and directly impose a high rate of DNA
repair activity.
The MRN complex function has been mainly characterized
in the context of DNA DSBs repair where it has a pivotal role in
sensing DNA lesions, activating ATM/ATR-dependent DDR,
tethering broken ends and allowing their rejoining.48 MRE11
nucleolitic activities appear to be crucial even for the choice of
which DNA DSB repair pathway should come into play.43,49,50
Most recent evidence, however, indicates an essential role of
the MRN complex also in faithful DNA replication. Indeed, it is
required to stabilize and restart stalled and collapsed
forks.11,12 MRE11 nucleolitic activity is essential for survival
in response to replication fork toxins in fission yeast.51 Its
exonuclease activity is involved in resecting newly replicated
DNA at collapsed forks,15,52 suggesting that also at these
sites, the MRN complex is necessary for licensing homo-
logous recombination, allowing replication restart. Consis-
tently, NBS1 KO is associated with the accumulation of
aberrant replication intermediates.16 Thus, it emerges that the
MRN complex directly participates in processing the 'stressed'
forks, more than just being involved in repairing DNA DSBs
generated at these locations.
All these mechanistic insights may be used to interpret how
MRN dysfunctions may lead to the dramatic CNS phenotypes
reported in mutation carriers and in the CNS-restricted NBS1
knockout mouse. It has been argued that the waves of rapid
and sustained cellular proliferation of neural progenitor cells
(i.e., cerebellar GCPs) would be associated with relevant
levels of replication stress and DNA damage strictly requiring
the protective role of the MRN complex. This hypothesis,
however, still remains largely speculative because direct
evidences of replication stress and/or DNA damage occurring
in physiologically proliferating neuronal precursors are scant
and their mechanisms of generation unknown. Filling these
gaps, we now show that the replication mode imposed by
a prominent regulator of neuronal progenitor cell expansion,
like MYCN, is a source of endogenous stress requiring the
MRN complex activity to prevent DNADSBs accumulation and
eventually cell death. Indeed, MYCN-dependent replication is
associated with appearance of known markers of replication
stress such as increased levels of chromatin-bound RPA,
CHK1 and RPA phosphorylation, and with DNA damage and
DDR activation. Genetic and pharmacological inactivation of
the MRN complex more strongly impairs MYCN-dependent,
rather than MYCN-independent, proliferation. Moreover,
MRE11 pharmacological inhibition results in DNA damage,
DDR and cell death not only in a MYCN overexpression
model, but also in the more physiological context of Mycn-
dependent and SAG-induced murine GCPs expansion.
Importantly, DNA damage unveiled by mirin and cell death
failed to occur if treatment started after completion of S-phase,
confirming they both depend on DNA replication.
Our data clearly indicate that the MRN complex is induced
by MYCN and is necessary to restrain the deleterious effects
of the replication stress. By contextualizing our observations
directly in continuous and primary neuronal cells, our data are
in line with and extend the observations of Brunh et al.16
reporting that the accumulation of aberrant replication inter-
mediates is responsible for DDR activation, p53-dependent
cell cycle slow down and cell death in NBS1-defective primary
mouse embryo fibroblasts. Interestingly, MRE11 pharmaco-
logical inhibition by mirin prevented activation of the ATR-
CHK1-dependent checkpoint, allowed cell cycle progression
in the presence of unrepaired DNA damage and caused cell
death, in MYCN overexpressing neuron-like cells. The
apparent inconsistency in the final outcome of MRN complex
inactivation in the two models might be related to the different
methodological approaches that were used: that is, depletion
by NBS1 KO versus MRE11 pharmacological inhibition.
Indeed, it has been shown that mirin and mirin-derived
selective inhibitors of MRE11 exonuclease activity prevent
end resection, RPA and RAD51 coating, and impair repair
via homologous recombination, leading to DNA DSBs
accumulation.49 In contrast, the selective inhibition of
MRE11 endonuclease activity (which works upstream of the
exonuclease activity) allows for DNA DSB repair via alter-
native pathways, limiting the accumulation of DNA damage.
Although the effects of these MRN inhibitors have not yet been
studied at stressed/collapsed replication forks, we speculate
that mirin and other MRE11 exonuclease inhibitors may allow
engagement of the MRN complex on collapsed forks, while
inhibiting its end-resection ability. This would impair RPA-
coating, ATR activation and fork restart via homologous
recombination. As a consequence, high levels of DNA DSB
would accumulate, eventually inducing cell death, all of which
we observed upon mirin treatment in our MYCN-dependent
replication stress model. Selective inhibition of MRE11
endonuclease activity might be predicted to impair the
engagements of the MRN complex on the collapsed forks,
leaving room for alternative pathways to intervene. Similar to
the absence of MRN components, this, however, could also
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Figure 6 The MRN complex controls replication stress during HH-induced
mouse cerebellar GCPs proliferation. (a) WB analysis of Mycn protein levels in freshly
isolated GPC (DIV0), SAG treated (48 h) GPCs and MYCN+ cells. (b) Tunel assays in
GPCs cultures pre-treated with SAG and then incubated with mirin for 18 h.
(c) Quantitation of the cells showing more than three 53BP1 foci in GPCs cultures
pre-treated with SAG and then incubated with mirin (6 h). (d) WB analysis of the
expression of the indicated proteins and phosphoepitopes in cells treated as in panel c.
(*Po0.05)
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lead to the accumulation of replication intermediates, check-
point activation and cell cycle slowdown, as reported for NBS1
deficiency by Bruhn et al.16
While our data clearly demonstrate that MYCN upregulates
the expression of the MRN complex to restrain the replication
stress it induces during neural cell proliferation, they also open
to the possibility that replication stress and the need for high
MRN complex activity is intrinsically associated with neural
progenitor cell expansion, perhaps also in CNS territories not
dependent on MYCN for their proliferation. Therfore, they
support the hypothesis that replication-born DNA damage is
responsible for the major neuronal defects associated with
MRN dysfunctions.
Materials and Methods
GPCs and neuron-like cell cultures. GPCs were isolated and grown as
described.53 Human neuron-like cells were as follows: LAN-5 were acquired from
Deutsche Sammlung Von Mikroorganismen und Zellkulturen (Braunschweig,
Germany; www.dsmz.de); SK-N-BE were obtained from European Collection of
Cell Cultures, (Porton Down, UK; www.ecacc.org.uk); SK-N-SH and LAN-1 were a
kind gift of Dr. Carol J. Thiele, CMBS, NCI, Bethesda, MD, USA. These cells were
grown in standard conditions54 and validated by genetic search of MYCN
amplification, p53 loss (for LAN-1) or other genetic aberrations. SHEP Tet21/N cells,
received from Dr. Schwabb, DKFZ, Heidelberg, Germany, were cultured as
reported55 and validated for MYCN inducibility in the presence or absence of
doxycycline (2 μg/ml). Differentiation of LAN-5 and SK-N-BE cells was obtained by
RA treatment (5 μM, Sigma Aldrich, St. Louis, MO, USA) for 4 and 15 days,
respectively.35 Hh pathway activation was obtained treating GPC culture with SAG
(0.2 μM, Alexis, Enzo Life Sciences, Inc, Farmingdale, NY, USA) for the indicated
times. The MRE11 inhibitor mirin (Sigma Aldrich) was used at 40 μM concentration.
S-phase synchronization was obtained by treating cells with thymidine (2.5 mM,
Sigma Aldrich) for 24 h. Hydroxyurea (Sigma Aldrich) was used at 1 mM
concentration for the indicated times.
Transfection, lentivirus infection and luciferase assay. MYCN-
expressing plasmid35 was transfected in SK-N-SH line with Lipofectamine Plus
Reagent (Invitrogen Corporation, San Diego, CA, USA). RNA interference experiments
were all performed using validated small interfering RNA sequences (Sigma Aldrich)
transfected by Dharmafect 2 Reagent (Thermo Fisher Scientific, Waltham, MA, USA)
or by means shRNA lentiviral transduction particles (Santa Cruz Biothecnology, Dallas,
TX, USA and Sigma Aldrich). IPTG-inducible NBS1 knockdown was obtained by
infecting SHEP TET21/N cells with Mission Custom shRNA lentiviral transduction
particles (pLKO-puro-IPTG-3xLacO-NBS1, Sigma Aldrich). Details on siRNA and
shRNA constructs are given as Supplementary materials. The NBS1 promoter
luciferase reporter construct (NBSluc-WT and NBSluc-mut) was a kind gift of Yu-Chi
Chiang.7 Luciferase assay was conducted on triplicate samples via a Dual luciferase
reporter assay (Promega Corporation, Madison, WI, USA) and measured by a Glomax
multidetection luminometer (Promega Corporation).
Cell proliferation, cell death analysis and cell cycle analysis.
MTS assay was performed using the MTS kit (Promega Corporation) according to
the manufacturer’s instructions. For BrdU incorporation assays, BrdU pulse was
applied to MYCN+/− cells for 2 h, and BrdU-staining was assayed by the 5-Bromo-
2′-deoxy-uridine Labeling and Detection Kit I (Roche Diagnostics, Indianapolis, IN,
USA). Cell proliferation and cell death were evaluated by plating an equal number of
cells and counting alive and death cells by trypan blue exclusion test at the indicated
time points and different conditions. For TUNEL staining, fixed cells were labeled
using the in situ Cell Death Detection Kit (Roche Diagnostics). At least 200 cells/
sample were counted and each experiment was performed at least three times. For
cell cycle analysis, cells were harvested, washed in succession with 10% FBS/PBS,
PBS, 50% FBS/0.1%NaN3/PBS, fixed in 70% ethanol ON at − 20 °C, washed twice
in 0.1%NaN3/PBS and resuspended in propidium iodide staining solution (50 μg/ml
propidium solution/PBS, RNase 40 μg/ml) for 30 min at room temperature. We
acquired at least 20 000 events. Fluorescence was measured using a FACSCanto II
(BD Biosciences, San Josè, CA, USA) and the percentages of cells in different
phases of the cell cycle were determined using the FlowJo V9.3.2 computer
software (TreeStar, Ashland, OR, USA).
Comet assay. Neutral comet assay was conducted as described56 with minor
modifications. Briefly, cell suspensions were mixed with low melting point agarose
(Bio-Rad, Hercules, CA, USA) at a final concentration of 0.5%, cast on a
microscope slide precoated with 1% agarose (Bio Optica, Milano, Italy). After
solidification, slides were immersed in cold neutral lysing solution (NaCl 2.5 M,
EDTA 0.1 M, Tris-HCl 0.01 M, N-Lauroyl-sarcosine 0.34 M, pH 9.5) for 2 h at 4 °C.
After lysis, the slides were placed on a horizontal gel electrophoresis unit (Bio-Rad)
filled with fresh electrophoretic buffer (sodium acetate 0.3 M and Tris-HCl 0.1M, pH
8). Electrophoresis was carried out for 30’ at fixed Volts and Ampere (40 mA). Slides
were stained with ethidium bromide and tail moment was measured by the Tritek
Comet Score TM freeware 1.6.1.13 Software (Tritek Corp., Sumerduck, VA, USA).
At least 200 cell/sample were counted and each experiment was performed at least
three times.
Immunofluorescence. Cells were fixed in 4% formaldehyde/PBS for 10 min
at RT, permeabilized and blocked in 3% goat serum in PBS and incubated with the
primary antibodies for 1 h at room temperature. Primary antibodies anti-β-tubulin
(#MAB1637, Millipore, Billerica, MA, USA) and 53BP1 (NB100-304, Novus
Biologicals, Littleton, CO, USA) were detected with AlexaFluor (Invitrogen
Corporation) secondary antibodies.
RNA and protein preparation, chromatin fractionation Q-PCR
and western blot. mRNA was extracted using TRIzol reagent (Invitrogen
Corporation) and quantitative reverse transcription-PCR was performed as
described.54 Primer sequences are given as Supplementary materials. Total
protein extraction and western blot protocol have been previously described.54
Chromatin fractionation was performed as described.57 Primary antibodies were as
follows: MYCN (B8.4.B), SC53993, p53 (DO-1) SC-126, CHK1 (G4), SC8408,
Tubulin, (TU-02), SC-8035, and β-Actin (I-19) SC-1616 Santa Cruz Biotechnology;
phospho-CHK1 (S317), DR1025, Calbiochem (San Diego, CA, USA); RAD50
(13B3/2C6), ab89, MRE11 (12D7) ab214, ZIC1 ab72694, Histone H3, ab1791,
phospho-ATM (Ser 1981), ab81292, Rad50, ab499, and Mre11, ab6511, Abcam
(Cambridge, UK); NBS1 (1C3) GTX70222, Gene Tex (Irvine, CA, USA); p53 (1C12),
#2524, phospho-p53 (Ser 15), #9284, and phospho- histone H2AX (ser 139),
#2577, Cell Signaling Technology (Danvers, MA, USA); PARP p85 fragment,
#G7341, Promega Corporation; RPA32, A300-244 A, phospho-RPA32 S4/S8, A300-
245 A, Bethyl Laboratories (Montgomery, TX, USA); Nbs1 (Y112), NB110-57272,
Novus Biologicals; Immunoreactive bands were visualized by enhanced chemo-
luminescence (Advansta Inc., Menlo Park, CA, USA).
Chromatin immunoprecipitation assay. Chromatin immunoprecipitation
assay was performed as described58 with minor modifications. Briefly, cross-linked
chromatin was lysed in buffer L2 (50 mM Tris-HCl pH 8.0, 5 mM EDTA pH 8.0, 0,5%
SDS, 150 mM NaCl plus protease inhibitors) and chromatin was sheared to
500–800 bp by sonication. Samples were centrifuged and supernatants were diluted
fivefold with dilution buffer (50 mM Tris-HCl pH 8.0, 5 mM EDTA, 200 mM NaCl,
0.5% NP40 plus protease inhibitors). Chromatin extracts were immunoprecipitated
overnight with anti-MYCN (Santa Cruz, sc-791), anti-acH3 (Millipore, 06-599) and
normal IgG as a control. The antibody-bound chromatin was collected with
pre-blocked Dynabeads protein A (Invitrogen Corporation) for 3 h at 4 °C. The
supernatant of the no antibody sample was saved as Input chromatin. Chromatin
immunoprecipitation complexes were washed three times for 5 min in RIPA buffer
(1% NP-40, 0.1% SDS, 1 mM EDTA, 50 mM Tris-HCl pH 8.0, 150 mM NaCl, 0.5%
deoxycholate plus protease inhibitors), once with LiCl buffer (Tris-HCl pH 8.0
10 mM, EDTA 1 mM, Deoxycholate 1%, NP40 1%, LiCl 250 mM) and twice with TE
buffer (Tris-HCl pH 7.5 10 mM, EDTA 1 mM). Extraction from the beads was
performed in 150 μl of elution buffer (1% SDS in TE) for 15 min at 65 °C. Cross-
linking was reversed by heating DNA complexes at 65 °C for at least 5 h after
addition of 200 mM NaCl, then digested with 100 ug/ml proteinase K for 2 h at
51 °C. DNA was extracted using Chromatin IP DNA purification kit (Active Motif,
Carlsbad, CA, USA). For each PCR reaction, 1/20 of the eluted DNA was used.
PCR primer sequences are given as Supplementary materials.
Statistical analysis. Statistical analysis was performed by a standard
two-tailed Student’s t test. Po0.05 was considered significant.
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